This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1979 Feb;66(2):303-10.

doi: 10.1016/0002-9343(79)90553-9.

Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy

J M Falko, J L Witztum, G Schonfeld, S W Weidman, J B Kolar

PMID: 218451
DOI: 10.1016/0002-9343(79)90553-9

Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy

J M Falko et al. Am J Med. 1979 Feb.

. 1979 Feb;66(2):303-10.

doi: 10.1016/0002-9343(79)90553-9.

Authors

J M Falko, J L Witztum, G Schonfeld, S W Weidman, J B Kolar

PMID: 218451
DOI: 10.1016/0002-9343(79)90553-9

No abstract available

PubMed Disclaimer

Similar articles

Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
Patsch JR, Yeshurun D, Jackson RL, Gotto AM Jr. Patsch JR, et al. Am J Med. 1977 Dec;63(6):1001-9. doi: 10.1016/0002-9343(77)90555-1. Am J Med. 1977. PMID: 204188 No abstract available.
[Familial hyperlipoproteinemia type III].
Patsch JR, Patsch W, Sailer S, Braunsteiner H. Patsch JR, et al. Dtsch Med Wochenschr. 1976 Oct 29;101(44):1612-9. doi: 10.1055/s-0028-1104313. Dtsch Med Wochenschr. 1976. PMID: 185039 Review. German. No abstract available.
Xanthomatosis and hyperlipoproteinemia; a review.
Polano MK. Polano MK. Dermatologica. 1974;149(1):1-9. Dermatologica. 1974. PMID: 4372111 No abstract available.
[Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P, Schwandt P. Weisweiler P, et al. Klin Wochenschr. 1977 Aug 15;55(16):791-4. doi: 10.1007/BF01651267. Klin Wochenschr. 1977. PMID: 198601 German.
Type IV hyperlipoproteinaemia.
Kwiterovich PO Jr, Margolis S. Kwiterovich PO Jr, et al. Clin Endocrinol Metab. 1973 Mar;2(1):41-71. doi: 10.1016/s0300-595x(73)80026-x. Clin Endocrinol Metab. 1973. PMID: 4359117 Review. No abstract available.

See all similar articles

Cited by

High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
Chappell DA. Chappell DA. J Clin Invest. 1989 Dec;84(6):1906-15. doi: 10.1172/JCI114378. J Clin Invest. 1989. PMID: 2556448 Free PMC article.
Diet and high density lipoproteins.
Oster P, Schlierf G, Heuck CC, Hahn S, Szymanski H, Schellenberg B. Oster P, et al. Lipids. 1981 Feb;16(2):93-7. doi: 10.1007/BF02535680. Lipids. 1981. PMID: 7242273
Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia).
Chappell DA. Chappell DA. J Clin Invest. 1988 Aug;82(2):628-39. doi: 10.1172/JCI113642. J Clin Invest. 1988. PMID: 2841358 Free PMC article.
Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia.
van Dam M, Zwart M, de Beer F, Smelt AH, Prins MH, Trip MD, Havekes LM, Lansberg PJ, Kastelein JJ. van Dam M, et al. Heart. 2002 Sep;88(3):234-8. doi: 10.1136/heart.88.3.234. Heart. 2002. PMID: 12181212 Free PMC article.
[The apolipoproteins in man ].
Schwandt P. Schwandt P. Klin Wochenschr. 1982 Jul 1;60(13):673-49. doi: 10.1007/BF01716796. Klin Wochenschr. 1982. PMID: 6750220 Review. German.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science